KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $984,500 | +15.0% | 93,053 | +32.9% | 0.00% | – |
| Q1 2023 | $855,990 | +511.0% | 69,991 | +520.0% | 0.00% | – |
| Q4 2022 | $140,096 | -59.9% | 11,289 | -55.8% | 0.00% | – |
| Q3 2022 | $349,000 | +3.9% | 25,519 | +39.2% | 0.00% | – |
| Q2 2022 | $336,000 | +103.6% | 18,333 | +78.4% | 0.00% | – |
| Q1 2022 | $165,000 | -70.4% | 10,276 | -74.2% | 0.00% | – |
| Q4 2021 | $558,000 | +142.6% | 39,843 | +223.9% | 0.00% | – |
| Q3 2021 | $230,000 | -45.0% | 12,300 | -38.6% | 0.00% | – |
| Q2 2021 | $418,000 | -33.3% | 20,045 | -9.6% | 0.00% | – |
| Q1 2021 | $627,000 | -79.8% | 22,181 | -76.7% | 0.00% | -100.0% |
| Q4 2020 | $3,107,000 | +9.6% | 95,121 | +2.8% | 0.00% | +100.0% |
| Q3 2020 | $2,836,000 | +544.5% | 92,535 | +189.2% | 0.00% | 0.0% |
| Q4 2019 | $440,000 | +64.2% | 31,996 | +134.8% | 0.00% | – |
| Q2 2019 | $268,000 | – | 13,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |